T1	Condition 26 39	heart failure
T2	Person 41 44	men
T3	Person 49 54	women
*	OR T2 T3
T4	Person 56 60	aged
T5	Value 61 70	>18 years
R1	Has_value Arg1:T4 Arg2:T5	
T7	Condition 0 11	Symptomatic
T6	Measurement 111 144	New York Heart Association (NYHA)
T8	Value 73 103	Functional class II, III or IV
R2	Has_value Arg1:T6 Arg2:T8	
T9	Measurement 146 180	Left ventricular ejection fraction
T10	Value 181 185	<35%
R3	Has_value Arg1:T9 Arg2:T10	
T11	Condition 187 195;212 220	Ischemic etiology
T12	Condition 200 220	nonischemic etiology
*	OR T12 T11
T13	Measurement 222 254	Type B natriuretic peptide (BNP)
T14	Value 255 265	>150 pg/ml
T15	Measurement 270 297	pro-BNP [N-terminal-proBNP]
T16	Value 298 311	= 600 pg / ml
R4	Has_value Arg1:T15 Arg2:T16	
R5	Has_value Arg1:T13 Arg2:T14	
*	OR T13 T15
T17	Procedure 335 347	hospitalized
T18	Condition 352 374	cardiac decompensation
T19	Temporal 375 405	within the preceding 12 months
R6	AND Arg1:T17 Arg2:T18	
R7	Has_temporal Arg1:T17 Arg2:T19	
T20	Scope 335 405	hospitalized for cardiac decompensation within the preceding 12 months
A1	Optional T20
T21	Measurement 407 410	BNP
T22	Value 411 421	>100 pg/ml
R8	Has_value Arg1:T21 Arg2:T22	
T23	Measurement 426 443	N-terminal-proBNP
T24	Value 444 457	= 400 pg / ml
R9	Has_value Arg1:T23 Arg2:T24	
*	OR T21 T23
T25	Scope 407 458	BNP >100 pg/ml (or N-terminal-proBNP = 400 pg / ml)
R10	Has_scope Arg1:T20 Arg2:T25	
T26	Scope 222 312	Type B natriuretic peptide (BNP) >150 pg/ml (or pro-BNP [N-terminal-proBNP] = 600 pg / ml)
*	OR T26 T20
